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(eGFR) was calculated from baseline creatinine levels and 
was divided in 3 subgroups: eGFR <60, 60–120 and >120 ml/
min/1.73 m 2 . Cox proportional hazard models were used to 
determine the effect of kidney dysfunction on mortality and 
incident vascular events, adjusting for cardiovascular risk 
factors.  Results: An eGFR <60 (HR 4.6; 95% CI 2.6–8.2) was 
associated with an increased risk of death and an increased 
risk of incident stroke (HR 4.1; 95% CI 1.9–9.0) independent 
of cardiovascular risk factors, but it was not associated with 
other vascular events. The point estimate for the 15-year cu-
mulative mortality was 70% (95% CI 46–94) for patients with 
a low eGFR, 24% (95% CI 18–30) for patients with a normal 
eGFR and 30% (95% CI 12–48) for patients with a high eGFR. 
The point estimate for the 15-year cumulative risk of incident 
stroke was 45% (95% CI 16–74) for patients with a low eGFR, 
13% (95% CI 9–17) for patients with a normal eGFR and 8% 
(95% CI 0–18) for patients with a high eGFR.  Conclusions: 
Kidney dysfunction is related to long-term mortality and 
stroke recurrence, but not to incident cardiovascular dis-
ease, on average 11 years after young stroke. This warrants 
a more intensive follow-up of young stroke patients with 
signs of kidney dysfunction in the early phase. In addition, 
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 Abstract 
 Background: In about 30% of young stroke patients, no 
cause can be identified. In elderly patients, kidney dysfunc-
tion has been suggested as a contributing risk factor for mor-
tality as well as stroke. There are hypotheses that novel non-
traditional risk factors, like chronic inflammation and oxida-
tive stress, are involved in chronic kidney disease, affecting 
the cerebral microvasculature that would in turn lead to 
stroke. Our objective is to investigate the influence of kidney 
dysfunction on long-term mortality and incident vascular 
events after stroke in young adults aged 18 through 50 and 
if this relationship would be independent of other cardiovas-
cular risk factors.  Methods: We prospectively included 460 
young stroke patients with an ischemic stroke or transient 
ischemic attack admitted to our department between 
 January 1, 1980 and November 1, 2010. Follow-up was done 
between 2014 and 2015. Estimated glomerular filtration rate 
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the clear association between kidney dysfunction and inci-
dent stroke seen in our young stroke population might be a 
first step in the recognition of kidney dysfunction as a new 
risk factor for the development of stroke at young age. Also, 
it can lead to new insights in the etiological differences be-
tween cardiovascular and cerebrovascular disease. 
 © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 In about 30% of young ischemic stroke (IS) patients, 
no cause can be identified despite an extensive diagnos-
tic work up  [1] . Recently, there has been an increase in 
interest in understanding the role of kidney dysfunction 
in the etiology and prognosis of stroke  [2, 3] since an 
increased prevalence of kidney dysfunction was ob-
served in stroke patients and was related to increased 
in-hospital mortality  [4] and increased long-term mor-
tality  [5–7] , although this trend was predominant in el-
derly stroke patients  [8] . To date, only one study de-
scribed a relationship between kidney dysfunction and 
increased long-term mortality and incident cardiovas-
cular disease in a young IS population, although the re-
lationship between kidney dysfunction and incident 
cardiovascular events was not found to be independent 
from cardiovascular risk factors  [9] .
 In elderly patients, the traditionally held view is that 
stroke and kidney dysfunction share identical traditional 
cardiovascular risk factors, such as hypertension and dia-
betes mellitus, and as such kidney dysfunction could be 
considered a surrogate marker for cerebrovascular dis-
ease, rather than an independent risk factor for stroke. 
Although these traditional risk factors are less prevalent 
in patients with stroke at young age and they have been 
exposed to these risk factors for a much shorter period of 
time, it cannot be excluded that kidney dysfunction is, 
even in these young patients, just a surrogate marker of 
cardiovascular disease. However, there are also hypoth-
eses that novel nontraditional risk factors, like chronic 
inflammation and oxidative stress, are involved in chron-
ic kidney disease, affecting the cerebral microvasculature, 
which in turn could lead to stroke  [8, 10] .
 As a first step in clarifying the relationship between 
kidney function and stroke at a young age, we wanted to 
investigate the relationship between kidney function at 
stroke onset, mortality and incident vascular events af-
ter stroke in young adults and if so, if this relationship 
would be independent of other cardiovascular risk fac-
tors.
 Methods 
 Patients and Study Design 
 This study is part of the ‘Follow-Up of Transient ischemic at-
tack and stroke patients and Unelucidated Risk factor Evaluation’ 
(FUTURE) study, a prospective cohort study that investigates 
causes and consequences of a young stroke  [11] . The Medical Re-
view Ethics Committee region Arnhem-Nijmegen approved the 
study. Written informed consent was obtained from all patients.
 In short, the FUTURE study comprised all consecutive pa-
tients with a transient ischemic attack (TIA), IS or intracerebral 
hemorrhage (ICH), between ages 18 and 50, admitted to the Rad-
boud University Medical Center between January 1, 1980 and 
 November 1, 2010. For this study, we only included patients with 
first-ever IS or TIA. Exclusion criteria were cerebral venous sinus 
thrombosis and retinal infarction. To minimize bias due to chang-
ing diagnostic techniques, the World Health Organization defini-
tion for TIA and stroke was used  [12, 13] . Stroke was defined as a 
rapidly evolving focal neurological deficit with no other than a 
vascular cause persisting for more than 24 h. On the basis of ra-
diological findings, stroke was subdivided into ICH and IS. TIA 
was defined similarly but with symptoms persisting for less than 
24 h.
 Patients were identified through a prospective registry of all 
consecutive young stroke patients that has been maintained at the 
department initiated in 1978  [14] , with a standardized collection 
of baseline and clinical characteristics  [11] .
 Cardiovascular risk factors at baseline were defined either as a 
history of a risk factor (mentioned in medical history or the use of 
medication) or as a risk factor detected during admission or during 
the analysis of the stroke, based on the following criteria: diabetes 
mellitus as a random blood glucose level >11.1 mmol/l or 2 con-
secutive fasting venous plasma glucose levels of  ≥ 7.0 mmol/l  [15] ; 
hypertension as systolic blood pressure  ≥ 135 mm Hg, diastolic 
blood pressure  ≥ 85 mm Hg, or both, measured after the first week 
of the index event; and atrial fibrillation when identified on either 
an electrocardiogram or during continuous electrocardiographic 
recording; dyslipidemia as a cholesterol level >5.0 mmol and/or 
LDL >2.5 mmol/l and/or a triglycerides of >2.0 mmol/l. Smoking 
was defined as smoking at least 1 cigarette per day in the year pri-
or to the event. A history of arterial disease was defined as a his-
tory of cardiac disease, including myocardial infarction and surgi-
cal treatment for coronary artery disease, or peripheral artery dis-
ease.
 Furthermore, all patients underwent a neurological examina-
tion and brain imaging at the time of their index event  [16] . The 
assessment of both the etiology (modified Trial of ORG 10172 in 
Acute Stroke Treatment (TOAST) classification)  [17] and sever-
ity (National Institutes of Health Stroke Scale (NIHSS)  [18] at ad-
mission) was done for all cases retrospectively by a validated ap-
proach  [19, 20] , as these scales did not exist at the time when a 
substantial proportion of our patients experienced their qualify-
ing event.
 Follow-Up 
 Information on the vital status was available either from hospi-
tal data or from the municipality registry. Patients alive were in-
vited for an extensive follow-up assessment between November 1, 
2009 and January 1, 2012, which included the assessment of inci-
dent events and the evaluation of cardiovascular risk factors. Sub-
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sequently, between August 1, 2014 and January 15, 2015, TIA and 
IS patients alive were approached by telephone to assess incident 
events. Of 17 surviving patients (3.7%), information about inci-
dent events was missing during the follow-up in 2014–2015; there-
fore, in these patients, follow-up data from the previous follow-up 
between 2009 and 2012 were used.
 The occurrence of incident strokes (IS or ICH) or other arte-
rial diseases (cardiac disease and peripheral artery disease) were 
assessed using a standardized, structured questionnaire. When-
ever an event was suspected, information was retrieved from the 
treating physicians and subsequently verified by specialists from 
the appropriate field. If information concerning a recurrent vascu-
lar event was not sufficient to confirm the diagnosis, it was consid-
ered a possible event and not used in the analyses.
 Outcome 
 The primary endpoint was death by any cause. Secondary out-
comes included any fatal or non-fatal incident arterial event, con-
sisting of fatal or non-fatal incident stroke (IS or ICH) and fatal or 
non-fatal other incident arterial disease (cardiac disease, including 
myocardial infarction, coronary artery bypass grafting and percu-
taneous coronary intervention for coronary artery disease, and pe-
ripheral artery disease)  [21] .
 Kidney Function 
 We included those patients for whom creatinine level readings 
were available within 1 month after the event (70.1% of the cohort). 
The median time between the index event and creatinine measure-
ment was 1 day (interquartile range 0–3 days). The Jaffe method 
was used for creatinine measurement until December 2005; there-
after, an enzymatic method, calibrated to IDMS traceable creati-
nine, was used. Jaffe values were recalculated to enzymatic values 
using a previously described correction factor  [22–24] . Estimated 
glomerular filtration rate (eGFR) was calculated from baseline cre-
atinine concentrations, using the chronic kidney disease-epidemi-
ology collaboration (CKD-EPI) equation  [25] . For patients under-
going dialysis, a constant eGFR value of 15 ml/min/1.73 m 2 was 
used (n = 2). eGFR was divided into 3 categories: low eGFR (<60 
ml/min/1.73 m 2 ), normal eGFR (60–120 ml/min/1.73 m 2 ) and 
high eGFR (>120 ml/min/1.73 m 2 )  [9] . GFR <60 ml/min/1.73 m 2 
is generally regarded as impaired renal function  [26] . Also, it is 
suggested that a GFR >120 ml/min/1.73 m 2 is related to an unfa-
vorable outcome  [27] . An eGFR >120 ml/min/1.73 m 2 can be re-
garded as hyperfiltration, which could be a sign of early kidney 
disease  [27] . However, a high eGFR can also be caused by comor-
bidity.
 Statistical Analysis 
 Univariate analysis was done to compare patients with an eGFR 
<60, 60–120 and >120 ml/min/1.73 m 2 on stroke subtype (TIA or 
IS), age, gender, cardiovascular risk factors and TOAST classifica-
tion using chi-square tests or Fisher’s exact tests when appropriate 
for categorical variables and analysis of variance or Kruskal–Wal-
lis tests for non-parametric continuous variables. Survival plots 
were made for cumulative mortality, incident arterial events and 
incident stroke, and other arterial diseases were stratified based on 
kidney function. Patients who died within 30 days after the index 
stroke were regarded as fatal cases and were therefore excluded 
from the mortality analysis  [11] . To ensure that the provided plots 
were reliable for all subgroups, survival plots were curtailed at 15 
years  [28] . Patients who did not reach an endpoint before follow-
up ended were censored.
 Cox proportional hazards models, adjusted for age, gender, the 
presence of hypertension, diabetes mellitus and/or a history of ar-
terial disease were used to calculate the relative risks for death and 
any fatal or non-fatal incident arterial event for patients with a low 
eGFR (<60 ml/min/1.73 m 2 ) compared to patients with a normal 
eGFR (60–120 ml/min/1.73 m 2 ) as the reference group. Patients 
with a high eGFR (>120 ml/min/1.73 m 2 ) could not be reliably 
compared with patients with a normal eGFR with regard to the oc-
currence of incident events, since the lines in the corresponding 
survival plots cross each other. This means that the assumption 
that the effect of the different variables on the outcome is constant 
over time (proportional hazards assumption) was not correct; this 
is however essential for a cox proportional hazard model. In addi-
tion, we repeated these analyses stratified by the time of admission 
(<1990, 1990–2000, >2000), to evaluate the effect of changes in 
diagnostic work-up and treatment over time. Also, we repeated the 
analysis including only those patients who had a creatinine level 
available within 1 day after their index event.
 At a young age, the mean GFR is substantially higher than at an 
older age, which could lead to the underestimation of young pa-
tients with impaired kidney function because their eGFR can be 
above 60 ml/min/1.73 m 2 , while still having a substantially lower 
eGFR than would be expected on the basis of their age. Therefore, 
we analyzed our data by dividing the eGFR in 3 other categories 
(below the 5th percentile (p5), above the 95th percentile (p95) and 
between p5 and p95 of the expected eGFR of the corresponding 
age group based on a previous validation study of the CKD-EPI 
equation in our hospital)  [23] . Furthermore, the analysis was re-
peated including only patients with an IS. p < 0.05 was considered 
significant. The statistical analysis was done using SPSS 20 for 
Windows.
 Results 
 Study Population 
 Of the 809 eligible patients, 153 refused to participate, 
and of 196 patients, baseline creatinine levels were un-
available. Therefore, only 460 patients (322 IS, 138 TIA) 
with a first ever stroke could participate in the current 
analysis. Compared to those enrolled in the study, pa-
tients who refused to participate were slightly younger 
(39.1 vs. 40.7 years, p = 0.008); no other differences in 
demographics or stroke characteristics were found. Com-
pared with patients with available baseline creatinine lev-
els, patients without this information were slightly young-
er (39.6 vs. 41.2 years, p  = 0.010) and had less severe 
strokes (median NIHSS 2 vs. 3, p < 0.001); no differences 
in any of the other baseline characteristics were found. 
The baseline characteristics of the study population are 
presented in  table 1 .
 After a mean follow-up of 11.5 (SD 8.3) years, 115 pa-
tients (25.0%) had died of which 21 patients (4.6%) were 
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case-fatalities. Fifty two patients (11.3%) had suffered 
from a fatal or non-fatal recurrent stroke and 59 patients 
(12.8%) from fatal or non-fatal other arterial events ( ta-
ble  2 ). Thirteen patients (2.3%) had both a recurrent 
stroke and another arterial event. Thirty two patients 
(61.5%) had their recurrent stroke at an age <50 years, 14 
patients (26.9%) between 50 and 60 years and only 6 pa-
tients (11.5%) >60 years.
 Kidney Dysfunction and Cumulative Risk of Mortality 
 The cumulative risk of mortality in patients with a low 
eGFR was significantly increased compared with the ref-
erence (log-rank p < 0.001;  fig. 1 ). The point estimate for 
the 15-year cumulative mortality was 70% (95% CI 46–
94) for patients with a low eGFR, 24% (95% CI 18–30) for 
patients with a normal eGFR and 30% (95% CI 12–48) for 
patients with a high eGFR. Both a low eGFR (HR 4.6; 95% 
Table 1.  Baseline characteristics
Total  eGFR, ml/min/1.73 m2 p value*
<6 0 60–120 >120
Total, n (%) 460 (100) 29 (6.3) 392 (85.2) 39 (8.5)
IS patients, n (%) 322 (70.0) 22 (75.9) 270 (68.9) 30 (76.9) 0.449
Age at event, years, mean ± SD 41.2±7.6 42.2±7.2 42.1±6.9 32.4±9.3 <0.001
Men, n (%) 218 (47.4) 18 (62.1) 178 (45.4) 22 (56.4) 0.111
NIHSS at admission, median (IQR) 3 (1–9) 4 (1–11) 3 (1–8) 9 (3–15) 0.001
Follow-up, years, mean ± SD 11.5±8.3 7.2±7.2 11.8±8.3 11.2±8.5 0.009
TOAST, n (%)
Large artery 107 (23.3) 8 (27.6) 93 (23.7) 6 (15.4) 0.426
Cardioembolism 65 (14.1) 7 (24.1) 51 (13.0) 7 (17.9) 0.195
Small vessel 51 (11.1) 5 (17.2) 44 (11.2) 2 (5.1) 0.279
Other determined 68 (14.8) 3 (10.3) 60 (15.3) 5 (12.8) 0.702
Multiple causes 10 (2.2) 2 (6.9) 8 (2.0) 0 0.165
Unknown 159 (34.6) 4 (13.8) 136 (34.7) 19 (48.7) 0.011
Hypertension, n (%) 162 (35.2) 21 (72.4) 132 (33.7) 9 (23.1) <0.001
Diabetes mellitus, n (%) 38 (8.3) 5 (17.2) 29 (7.4) 4 (10.3) 0.127
Dyslipidemia, n (%) 272 (80.7) 18 (94.7) 226 (79.0) 28 (87.5) 0.144
Atrial fibrillation, n (%) 9 (2.0) 0 9 (2.3) 0 1.000
Smoking, n (%)‡ 229 (52.4) 11 (45.8) 194 (51.3) 24 (68.6) 0.002
History of arterial events, n (%) 26 (5.7) 3 (10.3) 22 (5.6) 1 (2.6) 0.424
 ‡ 5.0% missing data.
IQR = Interquartile range.
* Chi-square tests or Fisher’s exact tests when appropriate, were used for categorical variables and analysis of 
variance or Kruskal–Wallis tests for (non-)parametric continuous variables.
Table 2.  Mortality and incident vascular events
Outcome Total  eGFR, ml/min/1.73 m2 p value*
<60 60–120 >120
Death from any cause, n (%) 115 (25.0) 18 (62.1) 85 (21.7) 12 (30.8) <0.001
<1 month after event 21 (4.6) 3 (10.3) 18 (4.6) 0 n/a
>1 month after event 94 (20.4) 15 (51.7) 67 (17.1) 12 (30.8) <0.001
Any vascular event, n (%) 98 (21.3) 11 (37.9) 82 (20.9) 5 (12.8) 0.048
Stroke (IS, ICH), n (%) 52 (11.3) 8 (27.6) 40 (10.2) 4 (10.3) 0.017
Other arterial events, n (%) 59 (12.8) 6 (20.7) 52 (13.3) 1 (2.6) 0.069
 * Chi-square tests were used to compare the number of deaths or events between eGFR categories. n/a = Not 
available.
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CI 2.6–8.2) and a high eGFR (HR 2.6; 95% CI 1.3–4.9) 
were associated with an increased risk of death after ad-
justment for age, gender and cardiovascular risk factors 
compared with the reference ( table 3 ).
 Kidney Dysfunction and Cumulative Risk of Incident 
Stroke 
 Cumulative risk of any incident vascular event in pa-
tients with a low eGFR was significantly increased com-
pared with the reference adjusted for age, gender and car-
diovascular risk factors (HR 2.5; 95% CI 1.3–4.7). Inci-
dent vascular events can be divided in incident stroke and 
other vascular incident events. The cumulative risk of in-
cident stroke in patients with a low eGFR was significant-
ly increased compared with the reference (log-rank p < 
0.001). The point estimate for the 15-year cumulative risk 
of incident stroke was 45% (95% CI 16–74) for patients 
with a low eGFR, 13% (95% CI 9–17) for patients with a 
normal eGFR and 8% (95% CI 0–18) for patients with a 
high eGFR ( fig. 2 a). The patients with a low eGFR were at 
increased risk for incident stroke (HR 4.1; 95% CI 1.9–
9.0) after adjustment for age, gender and cardiovascular 
risk factors.
 Kidney Dysfunction and Cumulative Risk of Incident 
Other Vascular Events 
 Cumulative risk of incident other vascular events in pa-
tients with a low eGFR was significantly increased com-
pared with the reference (log-rank p = 0.017). The point 
estimate for the 15-year cumulative risk of incident other 
vascular events was 23% (95% CI 3–43) for patients with 
a low eGFR, 17% (95% CI 11–23) for patients with normal 
eGFR and 3% (95% CI 0–9) for patients with a high eGFR. 
However, this effect was not statistically significant any-
more after adjustment for age, gender and cardiovascular 
risk factors (HR 2.1; 95% CI 0.9–5.0;  fig. 2 b).
 Stratification of Subgroups 
 The associations found between kidney dysfunction 
and the risk of mortality, incident stroke and incident 
other vascular events were similar for IS patients sepa-
rately, when all patients are stratified according to the 
time of their index event (<1990, 1990–2000, >2000) and 
when including patients of whom a creatinine level was 
available within 1 day after the index event (n = 284).
 Observed Compared to Expected Kidney Function 
 Sixty four patients (13.9%) had an observed eGFR <p5 
of the expected eGFR of which 35 patients (54.7%) had an 
eGFR >60 ml/min/1.73 m 2 , whereas 32 patients (7.0%) 
had an eGFR >p95 of the expected eGFR. Seventeen pa-
tients (43.6%) with an eGFR >120 ml/min/1.73 m 2 did 
have an eGFR between p5 and p95. The cumulative risks 
of mortality and incident vascular events for patients with 
an eGFR <p5, between p5 and p95 and >p95 of the ex-
pected eGFR were similar to the risks of those patients 
with an eGFR <60, 60–120 and >120 ml/min/1.73 m 2 , re-
spectively.
 Fig. 1. Cumulative mortality. 
Table 3.  Risk of all-cause mortality and incident vascular events in 
patients with kidney dysfunction
eGFR <60  eGFR >120
HR 95% CI  HR 95% CI
Death from any cause 4.6 2.6–8.2 2.6 1.3–4.9
Any vascular event 2.5 1.3–4.7 n/a*
Stroke 4.1 1.9–9.0
Other arterial events 2.1 0.9–5.0
 Normal eGFR (60–120 ml/min/1.73 m2) served as the reference 
group. Analysis was adjusted for gender, age and the presence of 
hypertension, diabetes mellitus and/or a history of arterial disease. 
* n/a = Not available; since the effect of an eGFR >120 ml/
min/1.73 m2 on the occurrence of incident events was not constant 
compared to the reference group, Cox proportional hazard analy-
sis was not performed.
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 Discussion 
 We showed that young stroke patients with kidney 
dysfunction (eGFR <60 ml/min/1.73 m 2 ) at baseline had 
a 15-year risk of death and recurrent stroke of 70 and 
45%, respectively. This risk was 4–5 times increased com-
pared to patients with an eGFR in the normal range, in-
dependent of co-occurring hypertension and/or diabetes 
mellitus. In contrast, there was no increased risk of other 
vascular events.
 Strengths of our study were the prospective and single-
center design, which allowed us to collect information 
systematically and uniformly both at baseline and follow-
up, thereby reducing the risk of information bias. Fur-
thermore, our study had one of the longest follow-up du-
rations reported.
 However, there are also some limitations. First, al-
though baseline creatinine levels were available from 
>70% of all participants, selection bias could have oc-
curred. Baseline creatinine levels were most often missing 
in those who had their initial stroke longer ago. A higher 
proportion of incident vascular events was seen in these 
patients in comparison to participants (21 vs. 11% for in-
cident stroke and 17 vs. 13% for other vascular events), 
while there was no difference in mortality. Also the 5-year 
risk of incident stroke was somewhat higher than expect-
ed in these patients (14% (no creatinine available) vs. 22% 
(eGFR <60); 6% (eGFR 60–120); 8% (eGFR >120)), sug-
gesting that there is an overrepresentation of patients 
with an incident stroke among the patients of whom we 
did not have a creatinine level available.
 Second, information bias could have occurred by us-
ing creatinine levels up to 1 month after the event. Al-
though it has been described that there can be some fluc-
tuation in creatinine levels in the first days after an ICH 
 [29] , we considered it unlikely that this time-window 
would affect the creatinine levels substantially. As expect-
ed we found similar results when the analysis was limited 
to only those patients who had a creatinine level available 
within 1 day after stroke.
 Furthermore, we are the first to relate the observed 
eGFR in our patients to the expected eGFR (defined by a 
healthy population) in an additional analysis, considering 
the age and gender of the patient to define poor kidney 
function. Thus, we controlled for misclassification of 
young patients with impaired kidney function who did 
have an eGFR >60 ml/min/1.73 m 2 as having a normal 
kidney function. This additional analysis showed similar 
associations between poor kidney function and the risk of 
death and incident strokes.
 Another possible cause of misclassification could be 
that the eGFR is based on only one creatinine measure-
ment, which might not reflect true kidney dysfunction in 
all cases. In some patients, the decreased eGFR might be 
due to other factors like stroke and dehydration. How-
ever, the possible overestimation of the total number of 
patients having kidney dysfunction, would lead to an un-
derestimation of the effect of kidney dysfunction on the 
endpoints.
 Previous studies have shown a clear relationship be-
tween poor kidney function and mortality, albeit in an 
elderly stroke population. Only one previous study de-
 Fig. 2. Cumulative risk of incident events.  a Cumulative risk of incident stroke.  b Cumulative risk of another arterial event. 
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scribed a similar relationship in young stroke patients; 
however, the mean follow-up was much shorter  [30] . 
They described a relationship between mortality and an 
eGFR <60 ml/min/1.73 m 2 and an eGFR >120 ml/
min/1.73 m 2 and mortality similar to our results  [9] . An 
increased eGFR >120 ml/min/1.73 m 2 can be regarded as 
hyperfiltration, which could be a sign of early kidney dis-
ease  [31] . However, a high eGFR can also be due to a low 
creatinine level caused by muscle wasting in patients with 
physical limitations after stroke (bedridden, wheel-chair 
bound). In these patients, increased mortality might be 
caused by comorbidity and might not be related to true 
kidney disease.
 In the elderly population, kidney dysfunction has been 
independently associated with increased risk of incident 
cardiovascular events after stroke  [31–33] . The previous-
ly mentioned study in young stroke patients also investi-
gated the relationship between kidney dysfunction and 
incident arterial events in a young stroke population  [9] . 
In contrast to our results, this association was not inde-
pendent of cardiovascular risk factors. Very interestingly, 
we could not establish an association between kidney dys-
function and other vascular events independent of hyper-
tension, diabetes mellitus and/or a history of vascular 
events. This suggests an additional pathophysiological 
mechanism underlying the association between kidney 
disease and incident stroke apart from traditional risk 
factors that does not affect other arteries. A possible ex-
planation for the increased risk of incident stroke is that 
progressive kidney dysfunction triggers increased blood 
pressures through several pathophysiological mecha-
nisms  [34] , possibly increasing the risk of stroke indepen-
dent of the presence of hypertension at baseline. It can be 
speculated that the heart is less vulnerable to hyperten-
sion itself, while the brain and kidney share a similar vas-
cular structure with low-resistance exposure of the small 
vessels to highly pulsatile flow and pressure  [8] . Also, 
there are hypotheses that novel nontraditional risk fac-
tors, like chronic inflammation and oxidative stress are 
involved, affecting the cerebral microvasculature  [8, 10] .
 In conclusion, kidney dysfunction at the time of a 
young stroke onset is related to an increased risk of long-
term mortality and stroke recurrence, but not to incident 
cardiovascular disease. This warrants a more intensive 
follow-up of young stroke patients with signs of kidney 
dysfunction in the early phase. Probably kidney dysfunc-
tion is not only a risk factor for poor outcome (increased 
mortality and increased risk of incident strokes). But the 
clear association between kidney dysfunction and inci-
dent stroke seen in our young stroke population might be 
a first step in considering kidney dysfunction a new risk 
factor for the development of stroke at young age. Also, 
this finding can lead to the discovery of new insights in 
terms of the etiological differences between cardiovascu-
lar and cerebrovascular disease.
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